Put Options

14 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$76.67 - $87.62 $16.3 Million - $18.6 Million
212,500 New
212,500 $16.6 Million
Q1 2022

May 17, 2022

SELL
$55.72 - $67.12 $5.58 Million - $6.72 Million
-100,172 Reduced 78.46%
27,500 $1.82 Million
Q4 2021

Feb 15, 2022

SELL
$54.02 - $63.83 $25.3 Million - $29.9 Million
-468,508 Reduced 78.58%
127,672 $7.44 Million
Q3 2021

Nov 16, 2021

BUY
$55.56 - $60.79 $11.9 Million - $13 Million
214,080 Added 56.03%
596,180 $35.8 Million
Q2 2021

Aug 16, 2021

BUY
$48.42 - $60.18 $2.52 Million - $3.13 Million
52,000 Added 15.75%
382,100 $22.9 Million
Q1 2021

May 18, 2021

SELL
$47.16 - $54.44 $7.72 Million - $8.91 Million
-163,700 Reduced 33.15%
330,100 $16.4 Million
Q4 2020

Feb 17, 2021

BUY
$48.52 - $58.02 $11.3 Million - $13.5 Million
233,500 Added 89.7%
493,800 $24.7 Million
Q3 2020

Nov 17, 2020

BUY
$53.07 - $61.1 $981,795 - $1.13 Million
18,500 Added 7.65%
260,300 $14.3 Million
Q2 2020

Aug 17, 2020

BUY
$43.1 - $55.31 $10.2 Million - $13.1 Million
237,300 Added 5273.33%
241,800 $12.8 Million
Q3 2019

Nov 14, 2019

SELL
$40.12 - $45.47 $742,220 - $841,195
-18,500 Reduced 80.43%
4,500 $201,000
Q1 2019

May 16, 2019

BUY
$35.49 - $43.02 $291,018 - $352,764
8,200 Added 55.41%
23,000 $930,000
Q4 2018

Feb 15, 2019

BUY
$36.86 - $41.49 $313,310 - $352,665
8,500 Added 134.92%
14,800 $562,000
Q2 2018

Aug 15, 2018

SELL
$34.55 - $37.05 $1.02 Million - $1.09 Million
-29,500 Reduced 82.4%
6,300 $221,000
Q1 2018

May 15, 2018

BUY
$32.97 - $36.63 $1.18 Million - $1.31 Million
35,800 New
35,800 $1.25 Million

Others Institutions Holding AZN

About ASTRAZENECA PLC


  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $203B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track Jane Street Group, LLC Portfolio

Follow Jane Street Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.